Indian pharma takes 'wait-and-watch' approach to tackle Trump's 200% tariff plan | What next?

From the publisher

Donald Trump announced a plan to bring drug manufacturing back to the US, imposing zero tariffs on imported generics for two years, and then increasing them to 100% and 200%.

The source's own excerpt, unedited